HopeStage
Back to all studies
CompletedNCT02220504

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Interventional studyAges 15–60SpainSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 15 years to 60 years.

Listed locations
SantanderSee all locations and recruitment
Study clarity

Study information

Study start dateStarted: July 2004
Recruitment status
Completed
Enrollment listed in the registry
68
Sponsor
Fundación Marques de Valdecilla
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
OTHER
Study phase
Not clearly listed
Locations
Spain
Age range
From 15 Years to 60 Years
Official registry ID
NCT02220504
Official title
Show the full official title

Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-episode Non-affective Psychosis Individuals: A 3-year Follow-up

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Santander

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Fundación Marques de Valdecilla.

Who was this study for?

Listed age limits: 15 years to 60 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me